Clinical Trials Directory

Trials / Completed

CompletedNCT04748562

Vaginal Progesterone 400mg v.s 200mg for Prevention of Preterm Labor in Twin Pregnancies

Vaginal Progesterone 400mg v.s 200mg for Prevention of Preterm Labor in Twin Pregnancies: a Randomised Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

It is already known that the risk of preterm labor in twin pregnancy before 37 week is 8-9 fold higher compared to singletons, and progesterone supplementation can decrease the incidence of preterm labor in singleton pregnancy. There were studies that used 200mg vaginal progesterone with no effect on the result So this study aims To examine the effect of prophylactic vaginal progesterone 400mg v.s 200mg for prevention of preterm birth in twin pregnancies

Conditions

Interventions

TypeNameDescription
DRUGProgesteroneTaking prontogest vaginally

Timeline

Start date
2020-01-01
Primary completion
2020-08-01
Completion
2020-12-01
First posted
2021-02-10
Last updated
2021-02-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04748562. Inclusion in this directory is not an endorsement.